IPIAD augments standard therapy for pancreatic ductal adenocarcinoma
A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added ...
Tag: Paclitaxel
ECOG-ACRIN launches new trial to evaluate nilotinib and paclitaxel for advanced cancers
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has enrolled the first patient in a new treatment trial to evaluate the effectiveness ...
Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma
A four-drug chemotherapy regimen provided longer overall survival than a two-drug combination in a Phase 3 clinical trial for metastatic ...
New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer
Pancreatic cancer is one of the deadliest types of cancer-;in the U.S., it is estimated that over 88 percent of ...
Study estimates the cost-effectiveness of therapeutic alternatives
Giving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce overall costs ...
Best available chemotherapy for HIV-related Kaposi sarcoma would save lives and be cost-effective in Africa
Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a ...
Chemo-immunotherapy combination shows promise against pancreatic cancer
A combination of chemotherapy with an immunotherapy meant to unleash the anticancer capacity of the immune system was effective against ...
